LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients

被引:9
作者
Wanka, Giulia [1 ]
Schmoeckel, Elisa [2 ]
Mayr, Doris [2 ]
Fuerst, Sophie [1 ]
Kuhn, Christina [1 ]
Mahner, Sven [1 ]
Knabl, Julia [1 ,3 ]
Karsten, Maria Margarete [4 ]
Dannecker, Christian [5 ]
Heidegger, Helene H. [1 ]
Vattai, Aurelia [1 ]
Jeschke, Udo [1 ,5 ]
Jueckstock, Julia [1 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Obstet & Gynecol, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Dept Pathol, Thalkirchner Str 142, D-80337 Munich, Germany
[3] Klin Hallerwiese, Dept Obstet, Sankt Johannis Muhlgasse 19, D-90419 Nurnberg, Germany
[4] Charite, Dept Gynecol & Gynecol Oncol, Charitepl 1, D-10117 Berlin, Germany
[5] Univ Hosp Augsburg, Dept Obstet & Gynecol, Stenglin St 2, D-86156 Augsburg, Germany
关键词
vulvar carcinoma; LDOC1; cancer survival; prognosis; NF-κ B; C-DIM; 12;
D O I
10.3390/ijms21239287
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
So far, studies about targeted therapies and predictive biomarkers for vulva carcinomas are rare. The leucine zipper downregulated in cancer 1 gene (LDOC1) has been identified in various carcinomas as a tumor-relevant protein influencing patients' survival and prognosis. Due to the lack of information about LDOC1 and its exact functionality, this study focuses on the expression of LDOC1 in vulvar carcinoma cells and its surrounding immune cells as well as its correlation to clinicopathological characteristics and prognosis. Additionally, a possible regulation of LDOC1 in vulvar cancer cell lines via the NF-kappa B signaling pathway was analyzed. Vulvar carcinoma sections of 157 patients were immunohistochemically stained and examined regarding LDOC1 expression by using the immunoreactive score (IRS). To characterize LDOC1-positively stained immune cell subpopulations, immunofluorescence double staining was performed. The effect of the NF-kappa B inhibitor C-DIM 12 (3,3 '-[(4-chlorophenyl)methylene]bis[1 H-indole]) on vulvar cancer cell lines A431 and SW 954 was measured according to MTT and BrdU assays. Baseline expression levels of LDOC1 in the vulvar cancer cell lines A431 and SW 954 was analyzed by real-time PCR. LDOC1 was expressed by about 90% of the cancer cells in the cytoplasm and about half of the cells in the nucleus. Cytoplasmatic expression of LDOC1 was associated with decreased ten-year overall survival of the patient, whereas nuclear staining showed a negative association with disease-free survival. Infiltrating immune cells were mainly macrophages followed by regulatory T cells. Incubation with C-DIM 12 decreased the cell viability and proliferation of vulvar cancer cell line A431, but not of cell line SW 954. LDOC1 expression on mRNA level was twice as high in the cell line A431 compared to the cell line SW 954. Overexpression of LDOC1 was associated with unfavorable overall and disease-free survival. Tumor growth could be inhibited by C-DIM 12 in vitro if the expressed LDOC1 level was high enough.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 41 条
[1]   The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy [J].
Abdulrahman, Ziena ;
Kortekaas, Kim E. ;
Van Steenwijk, Peggy J. De Vos ;
Van der Burg, Sjoerd H. ;
Van Poelgeest, Mariette I. E. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (12) :1223-1233
[2]   Epigenetic silencing of the LDOC1 tumor suppressor gene in ovarian cancer cells [J].
Buchholtz, Marie-Luise ;
Bruening, Ansgar ;
Mylonas, Ioannis ;
Jueckstock, Julia .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (01) :149-154
[3]   Loss of LDOC1 Expression by Promoter Methylation in Cervical Cancer Cells [J].
Buchholtz, Marie-Luise ;
Jueckstock, Julia ;
Weber, Elena ;
Mylonas, Ioannis ;
Dian, Darius ;
Bruening, Ansgar .
CANCER INVESTIGATION, 2013, 31 (09) :571-577
[4]   PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva [J].
Czogalla, Bastian ;
Pham, Deborah ;
Trillsch, Fabian ;
Rottmann, Miriam ;
Gallwas, Julia ;
Burges, Alexander ;
Mahner, Sven ;
Kirchner, Thomas ;
Jeschke, Udo ;
Mayr, Doris ;
Schmoeckel, Elisa .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) :569-577
[5]   The Nurr1 Activator 1,1-Bis(3′-Indolyl)-1-(p-Chlorophenyl) Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB [J].
De Miranda, Briana R. ;
Popichak, Katriana A. ;
Hammond, Sean L. ;
Jorgensen, Bryce A. ;
Phillips, Aaron T. ;
Safe, Stephen ;
Tjalkens, Ronald B. .
MOLECULAR PHARMACOLOGY, 2015, 87 (06) :1021-1034
[6]   LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients [J].
Duzkale, Hatice ;
Schweighofer, Carmen D. ;
Coombes, Kevin R. ;
Barron, Lynn L. ;
Ferrajoli, Alessandra ;
O'Brien, Susan ;
Wierda, William G. ;
Pfeifer, John ;
Majewski, Tadeusz ;
Czerniak, Bogdan A. ;
Jorgensen, Jeffrey L. ;
Medeiros, L. Jeffrey ;
Freireich, Emil J. ;
Keating, Michael J. ;
Abruzzo, Lynne V. .
BLOOD, 2011, 117 (15) :4076-4084
[7]   Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva [J].
Faber, Mette T. ;
Sand, Freja L. ;
Albieri, Vanna ;
Norrild, Bodil ;
Kjaer, Susanne K. ;
Verdoodt, Freija .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (06) :1161-1169
[8]   A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro [J].
Hammond, Sean L. ;
Safe, Stephen ;
Tjalkens, Ronald B. .
NEUROSCIENCE LETTERS, 2015, 607 :83-89
[9]   Squamous precursor lesions of the vulva: current classification and diagnostic challenges [J].
Hoang, Lien N. ;
Park, Kay J. ;
Soslow, Robert A. ;
Murali, Rajmohan .
PATHOLOGY, 2016, 48 (04) :291-302
[10]   The complexity of NF-κB signaling in inflammation and cancer [J].
Hoesel, Bastian ;
Schmid, Johannes A. .
MOLECULAR CANCER, 2013, 12